SANUWAVE Health (SNWV) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.96, -4.06% vs the prior close of $5.17.
- Volume 57.54K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SNWV slides 4.1% to $4.96. Closed at $4.96, -4.06% vs the prior close of $5.17. Day range $4.92β$5.29, opened at $5.23.
SNWV daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β SNWV slides 4.1% to $4.96
- Closed at $4.96, -4.06% vs the prior close of $5.17. Day range $4.92β$5.29, opened at $5.23.
- Volume was 57.54K shares, 0.9x its 50-day average of 66.66K.
- Price is +2.8% vs its 50-day average ($4.82) and -66.3% vs its 200-day average ($14.71).
- 52-week range $3.92β$36.42; today's close sits at 3% of that range, 86.4% below the 52-week high.
Oct 15, 2026 β SNWV rises 0.6% to $5.17
- Closed at $5.17, +0.58% vs the prior close of $5.14. Day range $5.06β$5.30, opened at $5.07.
- Volume was 39.80K shares, 0.6x its 50-day average of 66.97K β lighter than usual.
- Price is +6.7% vs its 50-day average ($4.84) and -65.2% vs its 200-day average ($14.84).
- 52-week range $3.92β$36.42; today's close sits at 4% of that range, 85.8% below the 52-week high.
Oct 14, 2026 β SNWV slides 8.4% to $5.14
- Closed at $5.14, -8.38% vs the prior close of $5.61. Day range $5.07β$5.36, opened at $5.36.
- Volume was 49.70K shares, 0.7x its 50-day average of 67.21K.
- Price is +5.8% vs its 50-day average ($4.86) and -65.7% vs its 200-day average ($14.96).
- 52-week range $3.92β$36.42; today's close sits at 4% of that range, 85.9% below the 52-week high.
Oct 13, 2026 β SNWV slides 3.9% to $5.61
- Closed at $5.61, -3.94% vs the prior close of $5.84. Day range $5.47β$5.90, opened at $5.90.
- Volume was 32.00K shares, 0.5x its 50-day average of 69.04K β lighter than usual.
- Price is +15.0% vs its 50-day average ($4.88) and -62.8% vs its 200-day average ($15.09).
- 52-week range $3.92β$36.42; today's close sits at 5% of that range, 84.6% below the 52-week high.
Oct 12, 2026 β SNWV jumps 3.9% to $5.84
- Closed at $5.84, +3.91% vs the prior close of $5.62. Day range $5.54β$5.98, opened at $5.74.
- Volume was 85.20K shares, 1.2x its 50-day average of 69.04K.
- Price is +19.4% vs its 50-day average ($4.89) and -61.6% vs its 200-day average ($15.22).
- 52-week range $3.92β$36.42; today's close sits at 6% of that range, 84.0% below the 52-week high.
Oct 9, 2026 β SNWV slides 3.8% to $5.62
- Closed at $5.62, -3.85% vs the prior close of $5.84. Day range $5.45β$5.86, opened at $5.82.
- Volume was 23.40K shares, 0.3x its 50-day average of 73.46K β lighter than usual.
- Price is +14.7% vs its 50-day average ($4.90) and -63.4% vs its 200-day average ($15.34).
- 52-week range $3.92β$36.42; today's close sits at 5% of that range, 84.6% below the 52-week high.
Oct 8, 2026 β SNWV jumps 5.5% to $5.84, a 1-month high, 3 up days in a row
- Closed at $5.84, +5.51% vs the prior close of $5.54. Day range $5.42β$5.88, opened at $5.50.
- Volume was 64.90K shares, 0.9x its 50-day average of 74.48K.
- Price is +19.0% vs its 50-day average ($4.91) and -62.2% vs its 200-day average ($15.46).
- 52-week range $3.92β$36.42; today's close sits at 6% of that range, 84.0% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 β SNWV jumps 6.5% to $5.54, a 1-month high
- Closed at $5.54, +6.54% vs the prior close of $5.20. Day range $5.19β$5.70, opened at $5.27.
- Volume was 104.10K shares, 1.4x its 50-day average of 75.05K.
- Price is +12.5% vs its 50-day average ($4.92) and -64.5% vs its 200-day average ($15.60).
- 52-week range $3.92β$36.42; today's close sits at 5% of that range, 84.8% below the 52-week high.
Oct 6, 2026 β SNWV jumps 10.6% to $5.20, a 1-month high
- Closed at $5.20, +10.64% vs the prior close of $4.70. Day range $4.75β$5.28, opened at $4.77.
- Volume was 51.40K shares, 0.7x its 50-day average of 76.24K.
- Price is +5.3% vs its 50-day average ($4.94) and -66.9% vs its 200-day average ($15.73).
- 52-week range $3.92β$40.87; today's close sits at 3% of that range, 87.3% below the 52-week high.
Oct 5, 2026 β SNWV dips 2.5% to $4.70
- Closed at $4.70, -2.49% vs the prior close of $4.82. Day range $4.57β$4.87, opened at $4.86.
- Volume was 38.50K shares, 0.5x its 50-day average of 77.66K β lighter than usual.
- Price is -5.2% vs its 50-day average ($4.96) and -70.4% vs its 200-day average ($15.87).
- 52-week range $3.92β$40.87; today's close sits at 2% of that range, 88.5% below the 52-week high.
Oct 2, 2026 β SNWV jumps 4.3% to $4.82
- Closed at $4.82, +4.33% vs the prior close of $4.62. Day range $4.69β$4.84, opened at $4.72.
- Volume was 20.50K shares, 0.3x its 50-day average of 79.54K β lighter than usual.
- Price is -3.3% vs its 50-day average ($4.98) and -69.9% vs its 200-day average ($16.00).
- 52-week range $3.92β$40.87; today's close sits at 2% of that range, 88.2% below the 52-week high.
SNWV latest news & SEC filings
Every SEC filing by or about SNWV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 25, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.01 β Stock exchange listing notice or transfer of listing.
Aug 14, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $9.74M (prior year $10.05M) (-3.1% vs Jun 30, 2025)
- Net income: -$682.00K (prior year $551.00K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.08 (prior year -$0.04) (loss widened vs Jun 30, 2025)
Jul 31, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 13, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade SNWV
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: Jul 13, 2026, May 12, 2026, Apr 16, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.09% (largest 10.6%). That is a volatile stock.
- Liquidity: about 53.83K shares (β$266.98K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.96 vs a range of $3.92β$36.42 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Management Inc. Opaleye sold 10,081 shares on May 1, 2026.
- Latest filings: 8-K Sep 25, 2026; 8-K Aug 6, 2026; 10-Q Aug 6, 2026.
- Share count: 8.60M shares outstanding (Aug 4, 2026), +0.4% vs a year earlier.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
SNWV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 5.23 | 5.29 | 4.92 | 4.96 | 57.54K |
| Oct 15, 2026 | 5.07 | 5.30 | 5.06 | 5.17 | 39.80K |
| Oct 14, 2026 | 5.36 | 5.36 | 5.07 | 5.14 | 49.70K |
| Oct 13, 2026 | 5.90 | 5.90 | 5.47 | 5.61 | 32.00K |
| Oct 12, 2026 | 5.74 | 5.98 | 5.54 | 5.84 | 85.20K |
| Oct 9, 2026 | 5.82 | 5.86 | 5.45 | 5.62 | 23.40K |
| Oct 8, 2026 | 5.50 | 5.88 | 5.42 | 5.84 | 64.90K |
| Oct 7, 2026 | 5.27 | 5.70 | 5.19 | 5.54 | 104.10K |
| Oct 6, 2026 | 4.77 | 5.28 | 4.75 | 5.20 | 51.40K |
| Oct 5, 2026 | 4.86 | 4.87 | 4.57 | 4.70 | 38.50K |
| Oct 2, 2026 | 4.72 | 4.84 | 4.69 | 4.82 | 20.50K |
| Oct 1, 2026 | 4.55 | 4.83 | 4.55 | 4.62 | 46.90K |
| Sep 30, 2026 | 4.58 | 4.79 | 4.57 | 4.71 | 44.40K |
| Sep 29, 2026 | 4.72 | 4.92 | 4.60 | 4.74 | 36.40K |
| Sep 28, 2026 | 5.07 | 5.07 | 4.51 | 4.65 | 68.80K |
| Sep 25, 2026 | 4.80 | 5.12 | 4.80 | 5.04 | 54.10K |
| Sep 24, 2026 | 4.73 | 4.96 | 4.56 | 4.85 | 96.30K |
| Sep 23, 2026 | 4.65 | 4.79 | 4.60 | 4.70 | 60.10K |
| Sep 22, 2026 | 4.19 | 4.64 | 4.19 | 4.64 | 47.30K |
| Sep 21, 2026 | 4.49 | 4.68 | 4.30 | 4.44 | 55.20K |
About SANUWAVE Health
SANUWAVE Health (SNWV) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in EDEN PRAIRIE, MN. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1417663.
SNWV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gregory Matthew Bazar | Director | Jul 2, 2026 |
| Jeffrey Blizard | Director | Jul 2, 2026 |
| Morgan C. Frank | Chief Executive Officer | Jul 2, 2026 |
| Ian D. Miller | Director | Jul 2, 2026 |
| James Tyler | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Daniel Coyle | Chief Operating Officer | Oct 6, 2025 |
| Morgan C. Frank | Chief Executive Officer | Jul 2, 2026 |
| David Timothy Wern | Exec VP of Sales | Feb 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 1, 2026 | Management Inc. Opaleye | Sale | 10,081 | $16.11 |
| May 1, 2026 | Management Inc. Opaleye | Sale | 500 | $16.11 |
| May 1, 2026 | Management Inc. Opaleye | Sale | 10,081 | $16.11 |
| May 1, 2026 | Management Inc. Opaleye | Sale | 500 | $16.11 |
| May 1, 2026 | Management Inc. Opaleye | Sale | 10,081 | $16.11 |
| May 1, 2026 | Management Inc. Opaleye | Sale | 500 | $16.11 |
| May 1, 2026 | Management Inc. Opaleye | Sale | 10,081 | $16.11 |
| May 1, 2026 | Management Inc. Opaleye | Sale | 500 | $16.11 |
| Apr 30, 2026 | Management Inc. Opaleye | Sale | 1,000 | $16.15 |
| Apr 30, 2026 | Management Inc. Opaleye | Sale | 24,000 | $16.15 |
| Apr 30, 2026 | Management Inc. Opaleye | Sale | 1,000 | $16.15 |
| Apr 30, 2026 | Management Inc. Opaleye | Sale | 24,000 | $16.15 |
| Apr 30, 2026 | Management Inc. Opaleye | Sale | 1,000 | $16.15 |
| Apr 30, 2026 | Management Inc. Opaleye | Sale | 24,000 | $16.15 |
| Apr 30, 2026 | Management Inc. Opaleye | Sale | 1,000 | $16.15 |
SNWV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $11.81M | 0.41 | $3.88M |
| Dec 31, 2024 | $32.33M | $-33.08M | -7.41 | $2.46M |
| Dec 31, 2023 | $19.25M | $-25.81M | -12.19 | $-4.54M |
| Dec 31, 2022 | $15.51M | $-10.29M | -0.02 | $-17.17M |
| Dec 31, 2021 | $11.38M | $-27.26M | -0.05 | $-6.41M |
Latest balance sheet: total assets $36.60M, total liabilities $33.82M, cash $9.38M (as of Jun 30, 2026).
SNWV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $6.00 |
| Jul 13, 2026 | 8-K Item 2.02 (results) | $11.26 |
| May 12, 2026 | 8-K Item 2.02 (results) | $16.04 |
| Apr 16, 2026 | 8-K Item 2.02 (results) | $18.02 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $18.85 |
| Nov 7, 2025 | 8-K Item 2.02 (results) | $31.08 |
| Aug 8, 2025 | 8-K Item 2.02 (results) | $39.76 |
| Jul 14, 2025 | 8-K Item 2.02 (results) | $36.16 |
| May 9, 2025 | 8-K Item 2.02 (results) | $30.10 |
| Apr 8, 2025 | 8-K Item 2.02 (results) | $30.81 |
| Mar 21, 2025 | 8-K Item 2.02 (results) | $37.61 |
| Jan 14, 2025 | 8-K Item 2.02 (results) | $28.25 |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SNWV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.